Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer

Colorectal cancer (CRC) is the third most common cause of cancer-related deaths worldwide, and 20% of patients with CRC present at diagnosis with metastases. The treatment of metastatic CRC is based on a fluoropyrimidine-based chemotherapy plus additional agents such as oxaliplatin and irinotecan. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Dazio, Giulia, Epistolio, Samantha, Frattini, Milo, Saletti, Piercarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783354/
https://www.ncbi.nlm.nih.gov/pubmed/36556139
http://dx.doi.org/10.3390/jcm11247523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783354/
https://www.ncbi.nlm.nih.gov/pubmed/36556139
http://dx.doi.org/10.3390/jcm11247523

Ejemplares similares